Tempur-Pedic Makes Donation To Pancreatic Cancer Action Network® At 2013 Las Vegas Market

 Tempur-Pedic Makes Donation To Pancreatic Cancer Action Network® At 2013 Las
                                 Vegas Market

PR Newswire

LEXINGTON, Ky., Jan. 29, 2013

LEXINGTON, Ky., Jan. 29, 2013 /PRNewswire/ --Tempur-Pedic International Inc.
(NYSE: TPX), a leading manufacturer, marketer and distributor of premium
mattresses and pillows worldwide,  made a special donation to the Pancreatic
Cancer Action Network at the 2013 Las Vegas Market on behalf of the first 250
show attendees who participated in a Tempur-Pedic^® Rest Test of its expanded
line of luxurious new mattress products, displayed in showroom C-1512. 

(Photo: http://photos.prnewswire.com/prnh/20130129/CG48906)

Attendees were invited to take a Rest Test and try the company's newest
product innovations. On behalf of Rest Test participants, Tempur-Pedic made an
additional donation of $12,500 to the Pancreatic Cancer Action Network in a
check ceremony as part of its 2012 total donation of $200,000.

Tempur-Pedic has a long history of supporting the Pancreatic Cancer Action
Network and its comprehensive approach to fighting pancreatic cancer through
research, providing vital patient support, community outreach and advocacy for
a cure. To date, the company has raised more than $1.25 million, in part to
help fund four research grants.

"Through our ongoing Tempur-Pedic Hugs Back campaign, we've enjoyed the
privilege of working with the Pancreatic Cancer Action Network for many years.
In 2013, we remain dedicated to supporting the network and plan to continue
bolstering it in any way possible by working with our retailers and our
organization, starting with this donation at the Las Vegas Market trade show,"
said Rick Anderson, president of Tempur-Pedic North America.

"Tempur-Pedic has had a tremendous impact on our organization and we are
extremely grateful for their ongoing support and dedication to this cause,"
added Julie Fleshman, president and CEO, Pancreatic Cancer Action Network.

Making a Difference in Battling Pancreatic Cancer

On Jan. 2, President Obama signed into law the Recalcitrant Cancer Research
Act, formerly the Pancreatic Cancer Research and Education Act. The landmark
legislation requires the National Cancer Institute (NCI) to examine its
current research efforts on cancers with very low survival rates and work to
develop early detection methods and better treatment options to help improve
outcomes for those diagnosed with the most deadly forms of cancer, including
pancreatic and lung cancer.

This year alone, pancreatic cancer will claim more than 37,000 lives. At 6
percent, the disease has the lowest five-year survival rate of any major
cancer, according to the Pancreatic Cancer Action Network. Passing of the
legislation was a major victory in the fight against the disease made possible
in part by the tireless efforts of the Pancreatic Cancer Action Network, its
network of thousands of volunteers and advocates around the country, along
with corporate donors such as Tempur-Pedic.

For more information on the Pancreatic Cancer Action Network, please visit
www.pancan.org. For more information on Tempur-Pedic and its products, or to
find an authorized retailer near you, visit tempurpedic.com.

About Tempur-Pedic

Tempur-Pedic International Inc. (NYSE: TPX) manufactures and distributes
mattresses and pillows made from its proprietary TEMPUR^® pressure-relieving
material. It is the worldwide leader in premium and specialty sleep. The
Company is focused on developing, manufacturing and marketing advanced sleep
surfaces that help improve the quality of life for people around the world.
The Company's products are currently sold in over 80 countries under the
TEMPUR^® and Tempur-Pedic^® brand names. World headquarters for Tempur-Pedic
International is in Lexington, Ky. For more information, visit tempurpedic.com
or call 800-805-3635.

About the Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the national organization creating
hope in a comprehensive way through research, patient support, community
outreach and advocacy for a cure. The organization is leading the way to
increase the survival rate for people diagnosed with this devastating disease
through a bold initiative — The Vision of Progress: Double the Pancreatic
Cancer Survival Rate by 2020. Together, we can know, fight and end pancreatic
cancer by intensifying our efforts to heighten awareness, raise funds for
comprehensive private research, and advocate for dedicated federal research to
advance early diagnostics, better treatments and increase chances of survival.
The organization also leads the Deadly Cancer Coalition, organizations
representing the nation's deadliest cancers defined as those cancers with a
five-year survival rate of less than fifty percent. Pancreatic cancer is the
deadliest with a five-year survival rate of just six percent.

Contact: Kaci Prunty (showroom C-1512)
Tempur-Pedic North America, LLC
(859) 421-4241
Kaci.Prunty@tempurpedic.com

Meredith Kish
Carmichael Lynch Spong
(212) 653-0655
Meredith.Kish@clynch.com

SOURCE Tempur-Pedic International Inc.

Website: http://www.tempurpedic.com
 
Press spacebar to pause and continue. Press esc to stop.